Chapter 3. β-Amyloid as a Target for Alzheimer's Disease Therapy
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 34, 21-30
- https://doi.org/10.1016/s0065-7743(08)60565-5
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1997
- The nanometer-scale structure of amyloid-Β visualized by atomic force microscopyProtein Journal, 1996
- Conformations of synthetic β peptides in solid state and in aqueous solution: relation to toxicity in PC12 cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Sulphated compounds attenuate β-amyloid toxicity by inhibiting its association with cellsNeuroReport, 1995
- X-ray Diffraction of Scrapie Prion Rods and PrP PeptidesJournal of Molecular Biology, 1995
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993
- Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequencesJournal of Molecular Biology, 1992
- Two‐way cleavage of β‐amyloid protein precursor by multicatalytic proteinaseFEBS Letters, 1992
- Putative N‐terminal splitting enzyme of amyloid A4 peptides is the multicatalytic proteinase, ingensin, which is widely distributed in mammalian cellsFEBS Letters, 1989
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984